A 5-year single-center review of Strongyloides seropositivity in kidney transplant candidates in Central Texas
- 27 September 2024
- journal article
- review article
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (1) , 21-25
Abstract
Strongyloides stercoralis is a soil-transmitted helminth that can lead to life-threatening hyperinfection in transplant recipients. Targeted screening based on social history alone may preclude a large proportion of seropositive patients. Our institution implemented universal screening for kidney transplant candidates. This study aimed to identify the prevalence and identify risk factors of transplant candidates. This was a retrospective chart review of kidney transplant candidates who were Strongyloides seropositive using the Strongyloides IgG enzyme-linked immunosorbent assay (ELISA) test. An equivocal Strongyloides serology was defined as 1.0 to 1.1 IV, a positive test as >1.1 IV, and a negative test as Strongyloides, and 121 (7.3%) tested positive. Forty-seven patients (38.8%) who tested positive had no reported travel history to endemic areas, and 86% of patients originated from the United States. Forty-six patients (97.9%) who received a kidney transplant received treatment with ivermectin, and none developed disseminated disease or hyperinfection. Among kidney transplant candidates screened for Strongyloides, 7.3% were seropositive and many reported no travel history to endemic areas, which highlights the significant prevalence of this parasite in Central Texas. Universal screening at our institution identified a substantial number of seropositive patients who might have otherwise been missed.Keywords
This publication has 19 references indexed in Scilit:
- Clinical and laboratory features of Strongyloides stercoralis infection at diagnosis and after treatment: a systematic review and meta-analysisClinical Microbiology and Infection, 2021
- Modeling strongyloidiasis risk in the United StatesInternational Journal of Infectious Diseases, 2020
- Strongyloidiasis hyperinfection after renal transplant presenting as diffuse alveolar hemorrhage with respiratory failureBaylor University Medical Center Proceedings, 2019
- Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017)Open Forum Infectious Diseases, 2019
- StrongyloidiasisInfectious Disease Clinics of North America, 2019
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infectionCochrane Database of Systematic Reviews, 2016
- Strongyloidiasis in Transplant PatientsClinical Infectious Diseases, 2009
- Disseminated strongyloidiasis: a retrospective study of clinical course and outcomeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Bacterial Complications of Strongyloidiasis: Streptococcus bovis MeningitisSouthern Medical Journal, 1999
- Clinical features of Strongyloides stercoralis infection in an endemic area of the United StatesGastroenterology, 1981